中国实用内科杂志2012，Vol.32Issue(9)：687-688,2.
生物制剂治疗类风湿关节炎经验与共识
Experience and consensus on biological agents for treatment of rheumatoid arthritis
张卓莉1
作者信息
- 1. 北京大学第一医院风湿免疫科,北京100034
- 折叠
摘要
Abstract
Biological agents,particularly tumor necrosis factor antagonists,have been the major advances in the treatment of rheumatoid arthritis. This could have been related to that fact that tumor necrosis factor antagonists may relieve the symptoms and signs including arthritis and morning stiffness,interrupt progression of bone damage and improve physical function and quality of life. The extensive application has enabled accumulation of mounting experiences and consensus in the treatment of rheumatoid arthritis. This may be worthwhile for Chinese clinicians to apply biological agents in an appropriate manner.关键词
生物制剂/肿瘤坏死因子拮抗剂/类风湿关节炎Key words
biological agent/tumor necrosis factor antagonist/rheumatoid arthritis分类
医药卫生引用本文复制引用
张卓莉..生物制剂治疗类风湿关节炎经验与共识[J].中国实用内科杂志,2012,32(9):687-688,2.
